Lori Harrelson

Former Vice President, Finance & Chief Accounting Officer at Argos Therapeutics, Inc.

Lori Harrelson

Lori Harrelson

Former Vice President, Finance & Chief Accounting Officer at Argos Therapeutics, Inc.

Biography

Lori R. Harrelson is former Vice President-Finance for Argos Therapeutics, Inc., former Finance Manager at LipoScience, Inc. and former Senior Auditor at Ernst & Young LLP. She received an undergraduate degree from East Carolina University.

Overview
RelSci Relationships

83

Birthday

1970

Age

51
Contact Data
Trying to get in touch with Lori Harrelson? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
View Relationship Details
RelSci Relationships are individuals Lori Harrelson likely has professional access to. A relationship does not necessarily indicate a personal connection.
Jeffrey D. Abbey

Chief Executive Officer & Director at Novadip Biosciences SA

Relationship likelihood: Average

Frederick M. Miesowicz

Senior Vice President & General Manager (Hybridon Specialty Products) at Idera Pharmaceuticals, Inc.

Relationship likelihood: Average

Charles A. Nicolette

Chief Executive Officer at CoImmune, Inc.

Relationship likelihood: Average

Timothy W. Trost

Chief Financial Officer at Werewolf Therapeutics, Inc.

Relationship likelihood: Average

John N. Bonfiglio

Former Chief Executive Officer & President at Imprimis Pharmaceuticals, Inc.

Relationship likelihood: Average

Clint G. Dederick, Jr.

Former President & Chief Executive Officer at Zynerba Pharmaceuticals, Inc.

Relationship likelihood: Average

Elaine Sale

Chief Operating Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Raisa Lowe

Director Quality Assurance at Argos Therapeutics, Inc.

Relationship likelihood: Average

Elliot Reno

Director at Argos Therapeutics, Inc.

Relationship likelihood: Average

Lothar H. Finke

Head-Clinical Development & General Manager-Japan at Incyte Corp.

Relationship likelihood: Average

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
GlobeNewswire
February 24, 2021
CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
GlobeNewswire
December 16, 2020
Chimeric antigen receptor (CAR)-modified cytokine induced killer cell (CAR-CIK) technology featured at ASH
GlobeNewswire
November 10, 2020
CoImmune, Inc. Announces Closing of $45 Million Series A Financing
Thomson Reuters ONE
April 30, 2020
CoImmune, Inc., a US-Based Clinical-Stage Biotech, Completes Merger with Formula Pharmaceuticals, Inc.
Thomson Reuters ONE
February 19, 2020
CoImmune, Inc. Announces FDA Approval of its IND Application to Conduct a Phase 2b Clinical Trial with CMN-001 in Advanced RCC Patients
Trending People
Chris A. Wray
Wray Defends FBI's Intelligence Sharing Ahead Of Jan. 6 Capitol Attack - npr.org
Carlos Ghosn Bichara
Your Wednesday Briefing - The New York Times
Lael Brainard
Lael Brainard hints that tumult in the bond market worried the Federal Reserve. - The New York Times
Rochelle Walensky
A Wave of Reopenings Takes Hold as Americans Ask Whether the Worst Is Over - The New York Times
Andrew Cuomo
Cuomo avoids public amid outcry over harassment allegations - Associated Press
Trending People
Chris A. Wray
Wray Defends FBI's Intelligence Sharing Ahead Of Jan. 6 Capitol Attack - npr.org
Carlos Ghosn Bichara
Your Wednesday Briefing - The New York Times
Lael Brainard
Lael Brainard hints that tumult in the bond market worried the Federal Reserve. - The New York Times
Rochelle Walensky
A Wave of Reopenings Takes Hold as Americans Ask Whether the Worst Is Over - The New York Times
Andrew Cuomo
Cuomo avoids public amid outcry over harassment allegations - Associated Press
Paths to Lori Harrelson
Potential Connections via
Relationship Science
You
Lori Harrelson
Former Vice President, Finance & Chief Accounting Officer at Argos Therapeutics, Inc.
Education
BS Finance
East Carolina University

East Carolina University in Greenville, North Carolina boasts several nationally recognized undergraduate and graduate programs. East Carolina offers bachelor’s, master’s, and doctoral degrees through its colleges of business, fine arts, health, dentistry, nursing and others. East Carolina University’s Brody School of Medicine is one of its more impressive divisions. Among medical schools emphasizing primary care Brody ranked sixth by U.S. News and World Report. It also ranked ninth for rural medicine. Also intensely involved in research, Brody is renowned for its innovative work in robotic surgery. Brody’s research is also continually expanding as they are also partnered with several growing research and clinical care facilities. Brody’s education department is also one of its more respected. Graduates of ECU’s College of Education have been named Teachers of the Year at the state and national levels. Another of its notable departments is the College of Fine Arts and Communications. Training individuals in the visual and performing arts, this division is one of the more well-known on the East Coast and hosts numerous performances, exhibits and arts programs. Additional offerings at ECU include adult learning options, a language academy and distance learning. Student services meet a range of needs and include a career center, a writing center, study abroad programs, student government, disability support, counseling, student legal services, a student health center, on-campus housing, financial aid for eligible students, and many others.

Career History
Vice President, Finance & Chief Accounting Officer
2004 - Prior
Argos Therapeutics, Inc.

Argos Therapeutics, Inc. is a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and is headquartered in Durham, NC.

Finance Manager
2001 - 2004
LipoScience, Inc.

LipoScience, Inc. is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 9 million NMR LipoProfile tests have been ordered. LipoScience's automated clinical analyzer, Vantera® has been cleared by the FDA. It requires no previous knowledge of NMR technology to operate and has been designed to dramatically simplify complex technology through ease of use and walk-away automation. Vantera will be placed with national and regional clinical laboratories. LipoScience is driving toward a clinical standard of care by decentralizing its technology and expanding its menu of personalized diagnostic tests to address a broad range of metabolic and other diseases.

Professional
1997 - 2001
Ernst & Young LLP

Ernst & Young LLP engages in the provision of assurance, tax, transactions, and advisory services. It offers audit, business risk, technology, security risk, and human capital services. The company was founded by Arthur Young and Alwin C. Ernst in 1989 and is headquartered in New York, NY.

Transactions
Details Hidden

Argos Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Argos Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Argos Therapeutics, Inc. raised money in a private placement transaction

Other Affiliations

Lori Harrelson is affiliated with Argos Therapeutics, Inc., LipoScience, Inc., Ernst & Young LLP

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lori Harrelson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lori Harrelson's profile does not indicate a business or promotional relationship of any kind between RelSci and Lori Harrelson.